First published online March 18, 2009
doi: 10.1242/10.1242/jcs.041913
Journal of Cell Science 122, 1025-1034 (2009)
Published by The Company of Biologists 2009
Distinct role of PLCβ3 in VEGF-mediated directional migration and vascular sprouting
Resham Bhattacharya1,
Junhye Kwon1,
Xiujuan Li2,
Enfeng Wang1,
Sujata Patra1,
John Paul Bida1,
Zeljko Bajzer1,
Lena Claesson-Welsh2 and
Debabrata Mukhopadhyay1,*
1 Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
2 Uppsala University, Department of Genetics and Pathology, Rudbeck Laboratory, Dag Hammarskjöldsv. 20, 751 85 Uppsala, Sweden

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1. IP1 production and phosphorylation of PLCs upon stimulation with VEGF. (A) HUVECs transfected with control scrambled siRNA or PLCβ3 siRNA were serum starved and stimulated with VEGF (10 ng/ml) for 1 hour, lysed and IP1 levels determined by ELISA assay. Results are means ± s.d. (B) Serum-starved HUVECs were stimulated with VEGF (10 ng/ml) for 0-5 minutes and immunoblotted with respective antibodies as shown.
|
|

View larger version (82K):
[in this window]
[in a new window]
|
Fig. 2. Immunofluorescent staining of embryoid bodies. (A-D) Embryoid bodies differentiated for 15 days were immunostained to detect CD31 (red), PLCβ3 or SerPLCβ3-P (green). Hoechst 3342 was used to detect nuclei (blue). Since no sprouts were formed in the absence of VEGF (A,B), in this instance, analysis was carried out on the core of the embryoid body. Weak immunostaining for PLCβ3 was detected, but there was no immunostaining for pPLCβ3. (A,B) Sprouting of angiogenic vessel-like structures, induced by VEGF treatment of embryoid bodies. (C,D) Colocalization of PLCβ3 and pPLCβ3 with CD31-positive endothelial cells in the presence of VEGF.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3. Specificity of VEGFR induces serine phosphorylation of PLCβ3. (A) Serum-starved HUVECs were pretreated with or without kinase inhibitor (100 nM) and then stimulated with or without 10 mg/ml VEGF for 5 minutes. Immunoblotting was performed with antibodies as shown. (B) HUVECs were infected with or without retrovirus expressing EGDR or EGLT for 48 hours. Tyrosine phosphorylation of EGDR or EGLT following EGF treatment was confirmed by immunoprecipitation with an N-terminal EGFR antibody followed by immunoblotting with antibody against Tyr-P. Expression of EGDR and EGLT was confirmed by immunoprecipitation with an N-terminal EGFR antibody followed by immunoblotting with antibodies against KDR or Flt-1. (C) HUVECs were infected with retrovirus expressing EGDR or EGLT for 48 hours, followed by treatment with EGF (10 ng/ml) and immunoblotting as shown.
|
|

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 5. Effect of PLCβ3 knockdown on actin reorganization. HUVECs bearing control-GFP or PLCβ3-GFP shRNA were selected with puromycin. HUVECs grown in culture slides were stimulated with 10 ng/ml VEGF for 30 minutes and then fixed and stained with phalloidin and DAPI. (A) HUVECs expressing control scrambled shRNA without any stimulation. (B) Cells from A stimulated with 10 ng/ml VEGF. (C) HUVECs expressing PLCβ3 shRNA stimulated with 10 ng/ml VEGF. (D) The percentage of stress-fiber-forming cells was calculated from five fields per well. Results show means ± s.d.
|
|

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 6. Effect of knockdown of PLCβ3 on activation of small GTPases. HUVECs were transfected with siRNA for PLCβ3 for 48 hours followed by starvation for 12-14 hours, and then stimulated with VEGF at 10 ng/ml. Lysates were immunoprecipitated with respective substrate GST-beads, and GTP-bound RhoA, Rac1 or CDC42 was detected by immunoblotting. Experiments were repeated at least three times. Normalized fold-change for each blot is shown as determined by NIH image densitometry.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 8. Effect of knockdown of PLCβ3 on VEGF-mediated proliferation and MAPK phosphorylation. (A) HUVECs were transfected with control scrambled or PLCβ3 siRNA using oligofectamine for 48 hours. 2x104 cells were plated in a 96-well plate, serum starved overnight and treated with 10 ng/ml VEGF for 48 hours before adding MTT. Proliferation assay was then performed. Data represent relative fold changes in absorbance at 490 nm ± s.d. Experiments were repeated at least three times, each time in triplicate (B) HUVECs transfected with control scrambled or PLCβ3 siRNA were serum starved overnight and treated with 10 ng/ml VEGF for the respective times, as described. Cell lysates were collected and western blotted with antibodies against MAPK-P or total MAPK.
|
|

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 9. Effect of PLCβ3 knockdown on cell cycle. (A) HUVECs transfected with control scrambled or PLCβ3 siRNA were serum starved overnight and treated with VEGF for 10 hours (A) or 24 hours (B). The cells were then fixed and stained with PI and analyzed by FACS. The mean percentage of cells with DNA content in each of the three phases of the cell cycle is shown over three independent determinations. Results are means ± s.d. (C) HUVECs transfected with control scrambled or PLCβ3 siRNA were serum starved overnight and treated with 10 ng/ml VEGF for 5 minutes. Cyclin D1, CDC2, cyclin A and PLC 1 were then detected by western blot of cell lysates. (D) Two-sided Student's t-test was performed on the data in A and B, and the corresponding P values are shown.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
© The Company of Biologists Ltd 2009